Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2016 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Sickle cell-hemoglobin E disease syndrome"
Page 1
Most adults with severe HbSC disease are not treated with hydroxyurea.
Ghunney WK, Asare EV, Ayete-Nyampong JB, Oppong SA, Rodeghier M, DeBaun MR, Olayemi E. Ghunney WK, et al. Blood Adv. 2023 Jul 11;7(13):3312-3319. doi: 10.1182/bloodadvances.2022009049. Blood Adv. 2023. PMID: 36799926 Free PMC article.
Sickle cell hemoglobin SC (HbSC) disease is the second most frequent sickle cell disease (SCD) genotype after sickle cell anemia (HbSS). ...We identified a comparison group of 639 individuals with HbSS and matched the frequency bas …
Sickle cell hemoglobin SC (HbSC) disease is the second most frequent sickle cell disease (SCD) gen …
Sickle cell-haemoglobin E (HbSE) compound heterozygosity: a clinical and haematological study.
Knox-Macaulay HH, Ahmed MM, Gravell D, Al-Kindi S, Ganesh A. Knox-Macaulay HH, et al. Int J Lab Hematol. 2007 Aug;29(4):292-301. doi: 10.1111/j.1365-2257.2006.00886.x. Int J Lab Hematol. 2007. PMID: 17617080 Review.
The paucity of clinical reports in the world literature suggests that, as a disease entity, haemoglobin SE compound heterozygosity is of negligible importance. ...At least 50% of those studied were asymptomatic throughout the study period but sickling-related compli …
The paucity of clinical reports in the world literature suggests that, as a disease entity, haemoglobin SE compound heterozygosity is …
Rheology of red blood cells in patients with HbC disease.
Lemonne N, Billaud M, Waltz X, Romana M, Hierso R, Etienne-Julan M, Connes P. Lemonne N, et al. Clin Hemorheol Microcirc. 2016;61(4):571-7. doi: 10.3233/CH-141906. Clin Hemorheol Microcirc. 2016. PMID: 25335812
Patients with hemoglobin C disease (CC) usually do not develop severe complications in comparison with individuals with sickle cell anemia (SS) or with sickle cell hemoglobin C disease (SC). ...Blood viscosity was measured at 225 s(-1) wi …
Patients with hemoglobin C disease (CC) usually do not develop severe complications in comparison with individuals with sickle …